Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Vir Biotechnology, Inc. (VIR)  
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 127,390,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $0 - $0
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Vir Biotechnology is a commercial-stage immunology company focused on combining immunologic insights with technologies to treat and prevent serious infectious diseases. Co.'s existing pipeline consists of sotrovimab and other product candidates targeting COVID-19, hepatitis B virus, influenza A virus, and human immunodeficiency virus. Co. has collaborate with Glaxo Wellcome UK Limited and GlaxoSmithKline Biologicals S.A. to focus on treating and preventing severe acute respiratory syndrome coronavirus 2 (the virus that causes COVID-19 illness). Co. is developing differentiated monoclonal antibodies, like sotrovimab and VIR-7832, as well as vaccines and small molecules.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 10,000
Total Buy Value $0 $0 $0 $246,341
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 4
Total Shares Sold 167,399 167,399 965,615 6,005,613
Total Sell Value $1,671,921 $1,671,921 $22,530,609 $153,953,368
Total People Sold 5 5 9 11
Total Sell Transactions 10 10 26 123
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 575
  Page 3 of 23  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Softbank Vision Fund (aiv M1) L.p. 10% Owner   –       –       •   2023-05-03 4 AS $25.51 $2,134,691 I/I (83,674) 17,751,051     -
   Softbank Vision Fund (aiv M1) L.p. 10% Owner   –       –       •   2023-05-01 4 AS $25.30 $77,812 I/I (3,075) 17,834,725     -
   Softbank Vision Fund (aiv M1) L.p. 10% Owner   –       –       •   2023-04-25 4 AS $25.30 $24,313 I/I (961) 17,837,800     -
   Softbank Vision Fund (aiv M1) L.p. 10% Owner   –       –       •   2023-04-24 4 AS $25.42 $1,678,633 I/I (66,038) 17,838,761     -
   Softbank Vision Fund (aiv M1) L.p. 10% Owner   –       –       •   2023-04-21 4 AS $25.76 $7,872,247 I/I (305,393) 17,904,799     -
   Softbank Vision Fund (aiv M1) L.p. 10% Owner   –       –       •   2023-04-20 4 AS $25.06 $165,147 I/I (6,590) 18,210,192     -
   Softbank Vision Fund (aiv M1) L.p. 10% Owner   –       –       •   2023-04-19 4 AS $25.12 $1,911,968 I/I (76,114) 18,216,782     -
   Softbank Vision Fund (aiv M1) L.p. 10% Owner   –       –       •   2023-04-18 4 AS $25.12 $174,661 I/I (6,953) 18,292,896     -
   Softbank Vision Fund (aiv M1) L.p. 10% Owner   –       –       •   2023-04-17 4 AS $25.06 $263,741 I/I (10,524) 18,299,849     -
   Softbank Vision Fund (aiv M1) L.p. 10% Owner   –       –       •   2023-04-14 4 AS $25.11 $240,152 I/I (9,565) 18,310,373     -
   Lee Sung Chief Financial Officer   •       –      –    2023-03-27 4 A $0.00 $0 D/D 66,500 66,500     -
   Sato Vicki L Director   –       •      –    2023-03-08 4 AS $22.59 $405,062 D/D (17,935) 1,327,324     -
   Friedl-Naderer Johanna EVP & Chief Operating Officer   •       –      –    2023-03-03 4 S $22.82 $33,819 D/D (1,482) 148,518     -
   Sigal Charles Elliott Director   –       •      –    2023-03-01 4 AB $22.73 $56,816 I/I 2,500 10,000     -
   Pang Phillip Chief Medical Officer   •       –      –    2023-02-27 4 AS $23.00 $238,170 D/D (10,320) 188,000     -
   Scangos George A President and CEO   •       •      –    2023-02-24 4 AS $22.74 $352,682 D/D (15,119) 168,489     -
   Horn Howard CFO   •       –      –    2023-02-23 4 S $25.97 $58,387 D/D (2,248) 230,712     -
   Hanly Ann M. Chief Technology Officer   •       –      –    2023-02-23 4 S $25.97 $59,790 D/D (2,302) 117,203     -
   Rice Steven J. Chief Administrative Officer   •       –      –    2023-02-23 4 S $25.97 $46,622 D/D (1,795) 108,414     -
   Scangos George A President and CEO   •       •      –    2023-02-23 4 AS $25.97 $328,065 D/D (12,631) 183,608     -
   Pang Phillip Chief Medical Officer   •       –      –    2023-02-23 4 S $25.97 $74,750 D/D (2,878) 198,320     -
   Hanly Ann M. Chief Technology Officer   •       –      –    2023-02-22 4 A $0.00 $0 D/D 37,500 119,505     -
   Rice Steven J. Chief Administrative Officer   •       –      –    2023-02-22 4 A $0.00 $0 D/D 73,000 110,209     -
   Friedl-Naderer Johanna EVP & Chief Operating Officer   •       –      –    2023-02-22 4 A $0.00 $0 D/D 60,000 150,000     -
   Pang Phillip Chief Medical Officer   •       –      –    2023-02-22 4 A $0.00 $0 D/D 60,000 201,198     -

  575 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 3 of 23
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed